1928PPathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC). (23rd October 2018) - Weissferdt, A; Sepesi, B; Pataer, A; Kalhor, N; Moran, C A; William, W N; Le, X; Glisson, B; Skoulidis, F; Blumenschein, G; Zhang, J; Altan, M; et al.